TOTM Technologies Limited (SGX:42F)
Singapore · Delayed Price · Currency is SGD 0.0250
-0.0010 (-3.85%)
At close: Aug 11, 2025
Orchard Therapeutics Income Statement
Financials in millions SGD. Fiscal year is June - May.
Millions SGD. Fiscal year is Jun - May.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 | May '21 May 31, 2021 | 2016 - 2020 |
Operating Revenue | 8.09 | 6.52 | 19.37 | 11.13 | 1.02 | Upgrade |
| 8.09 | 6.52 | 19.37 | 11.13 | 1.02 | Upgrade | |
Revenue Growth (YoY) | 24.15% | -66.35% | 74.05% | 995.18% | -91.20% | Upgrade |
Cost of Revenue | 3.08 | 1.48 | 14.23 | 7.27 | 0.15 | Upgrade |
Gross Profit | 5.02 | 5.03 | 5.14 | 3.85 | 0.87 | Upgrade |
Selling, General & Admin | 4.92 | 7.19 | 7.54 | 6.83 | 5.61 | Upgrade |
Other Operating Expenses | 2.14 | 2.33 | 2.73 | 1.54 | 0.29 | Upgrade |
Operating Expenses | 13.36 | 16.48 | 16.97 | 13.87 | 6.75 | Upgrade |
Operating Income | -8.34 | -11.45 | -11.83 | -10.01 | -5.89 | Upgrade |
Interest Expense | -0.11 | -0.09 | -0.08 | -0.18 | -0.13 | Upgrade |
Interest & Investment Income | - | 0.01 | 0.02 | - | 0 | Upgrade |
Earnings From Equity Investments | 0.86 | -0.54 | -0.55 | -0.91 | - | Upgrade |
Currency Exchange Gain (Loss) | - | -0.06 | -0.15 | -0.1 | - | Upgrade |
Other Non Operating Income (Expenses) | 0.22 | 0.02 | 0.01 | 0.02 | 0.04 | Upgrade |
EBT Excluding Unusual Items | -7.38 | -12.12 | -12.58 | -11.19 | -5.98 | Upgrade |
Merger & Restructuring Charges | - | - | - | -2.52 | - | Upgrade |
Impairment of Goodwill | -20.65 | - | - | - | - | Upgrade |
Gain (Loss) on Sale of Investments | -3.81 | - | - | - | 0.46 | Upgrade |
Other Unusual Items | - | 0.01 | 0.18 | 0.18 | 0.03 | Upgrade |
Pretax Income | -31.84 | -12.1 | -12.4 | -13.52 | -5.5 | Upgrade |
Income Tax Expense | -0.53 | -0.59 | -0.48 | -0.71 | -0.02 | Upgrade |
Earnings From Continuing Operations | -31.31 | -11.52 | -11.92 | -12.82 | -5.48 | Upgrade |
Earnings From Discontinued Operations | - | - | - | 0.5 | -2.93 | Upgrade |
Net Income to Company | -31.31 | -11.52 | -11.92 | -12.32 | -8.41 | Upgrade |
Minority Interest in Earnings | -0.01 | -0.08 | 0.58 | 1.78 | 0.09 | Upgrade |
Net Income | -31.32 | -11.59 | -11.34 | -10.54 | -8.32 | Upgrade |
Net Income to Common | -31.32 | -11.59 | -11.34 | -10.54 | -8.32 | Upgrade |
Shares Outstanding (Basic) | 1,354 | 1,341 | 1,064 | 834 | 322 | Upgrade |
Shares Outstanding (Diluted) | 1,354 | 1,341 | 1,064 | 834 | 322 | Upgrade |
Shares Change (YoY) | 0.99% | 25.98% | 27.61% | 158.85% | 112.01% | Upgrade |
EPS (Basic) | -0.02 | -0.01 | -0.01 | -0.01 | -0.03 | Upgrade |
EPS (Diluted) | -0.02 | -0.01 | -0.01 | -0.01 | -0.03 | Upgrade |
Free Cash Flow | -0.85 | -6.31 | -6.1 | -8.55 | -2.01 | Upgrade |
Free Cash Flow Per Share | -0.00 | -0.01 | -0.01 | -0.01 | -0.01 | Upgrade |
Gross Margin | 61.98% | 77.24% | 26.53% | 34.64% | 85.43% | Upgrade |
Operating Margin | -103.08% | -175.65% | -61.07% | -89.99% | -579.23% | Upgrade |
Profit Margin | -387.10% | -177.89% | -58.54% | -94.72% | -818.50% | Upgrade |
Free Cash Flow Margin | -10.47% | -96.84% | -31.47% | -76.81% | -197.93% | Upgrade |
EBITDA | -2.35 | -5.45 | -5.89 | -4.36 | -4.94 | Upgrade |
EBITDA Margin | -29.04% | -83.57% | -30.41% | -39.21% | - | Upgrade |
D&A For EBITDA | 5.99 | 6 | 5.94 | 5.65 | 0.94 | Upgrade |
EBIT | -8.34 | -11.45 | -11.83 | -10.01 | -5.89 | Upgrade |
EBIT Margin | -103.08% | -175.65% | -61.07% | -89.99% | - | Upgrade |
Updated Jan 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.